| Amgen (7) |  |
| Biogen idec (8) | |
| Biotechnology company (49) | |
| Celgene (3) | |
| Amgen (7) | |
| Biogen idec (8) | |
| Biotechnology company (49) | |
| Celgene (3) | |
Representatives of two other top-selling cancer drug developers, Celgene and Amgen, at deadline had responded not to GEN queries on indication pricing
A new trial will commence shortly using the Celgene CC-115 DNA-PKCS inhibitor. This new trial will be for patients advancing on standard of care therapies,
#After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial Juno Therapeutics has built remarkable momentumncluding last week much-dissected $1 billion deal with Celgenepon
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011